BMJ

Diagnosis and management of adult onset Still’s disease

1 Department of Medicine, Division of Allergy, Immunology, and Rheumatology, New Jersey Medical School, UMDNJ, Newark, NJ 07101, USA 2 Department of Medicine, Weill Medical College of Cornell ...
BMJ

CDAI and DAS28 in the management of rheumatoid arthritis in clinical practice

The primary therapeutic target for rheumatoid arthritis is remission, assessed using validated composited measures.1 Currently, index-based remission frequently used in clinical practice are disease ...
BMJ

Epidemiology of whiplash: an international dilemma

562 Heritage Medical Research Centre, University of Alberta, Edmonton, Alberta, Canada TG6 2S2 Whiplash associated disorders have become an international medicolegal and social dilemma. Physicians are ...
BMJ

Long-term intake of dietary long-chain n-3 polyunsaturated fatty acids and risk of rheumatoid arthritis: a prospective cohort study of women

Correspondence to Professor Alicja Wolk, Division of Nutritional Epidemiology, Institute of Environmental Medicine, Karolinska Institutet, Box 210, Stockholm 171 77, Sweden; Alicja.Wolk{at}ki.se ...
BMJ

OP0229 THE GROUP FOR RESEARCH AND ASSESSMENT OF PSORIASIS AND PSORIATIC ARTHRITIS (GRAPPA) TREATMENT RECOMMENDATIONS 2021

Background: Since the 2015 GRAPPA treatment recommendations were published, therapeutic options and management strategies for psoriatic arthritis (PsA) have advanced considerably. Objectives: The goal ...
BMJ

The 2019 American College of Rheumatology/European League Against Rheumatism classification criteria for IgG4-related disease

Correspondence to Dr John H Stone, Massachusetts General Hospital Rheumatology Unit, Harvard Medical School, Boston, MA 02114, USA; jhstone{at}mgh.harvard.edu IgG4-related disease (IgG4-RD) can cause ...
BMJ

Efficacy of TNFα blockers in patients with ankylosing spondylitis and non-radiographic axial spondyloarthritis: a meta-analysis

Objectives This meta-analysis investigates the efficacy of tumour necrosis factor α (TNFα) blockers versus placebo for the treatment of ankylosing spondylitis (AS) and non-radiographic axial ...
BMJ

A nationwide non-medical switch from originator infliximab to biosimilar CT-P13 in 802 patients with inflammatory arthritis: 1-year clinical outcomes from the DANBIO registry

1 The DANBIO registry and Copenhagen Center for Arthritis Research (COPECARE), Center for Rheumatology and Spine Diseases, Centre of Head and Orthopaedics, Rigshospitalet, Glostrup, Denmark Objectives ...
BMJ

POS1149 COMPARISON OF THE EFFICACY AND SAFETY OF TELITACICEPT VERSUS BELIMUMAB IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS IN REAL CLINICAL PRACTICE ...

Background Systemic lupus erythematosus (SLE) is a multi-system autoimmune disease characterized by aberrant expansion of B cells. The B cell-stimulating molecules, B cell activating factor/a ...
BMJ

Combination of IL-17 and TNFα induces a pro-inflammatory, pro-coagulant and pro-thrombotic phenotype in human endothelial cells

Department of Clinical Immunology and Rheumatology, Immunogenomics and Inflammation Research Unit, Hopital Edouard Herriot, University of Lyon, Lyon, France Correspondence to Professor Pierre Miossec, ...
BMJ

The spine in sport and veteran military parachutists

Spinal injuries and symptoms were studied in 109 ex-military parachutists and 112 sport (free fall) parachutists by means of postal questionnaires. 46 ex-military parachutists aged 50 years or over ...
BMJ

A disease activity score for polymyalgia rheumatica

Objective: To develop a composite score for measurement of disease activity in polymyalgia rheumatica (PMR) and assess its internal and external validity. Methods: A PMR activity score (AS) was ...